Issues related to anti-trust and competition
Source-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2025
- Income
- Not reported
- Expenses
- $2,080,000.00
- Registrant
- MEDTRONIC, INC.
- Client
- MEDTRONIC INC
- Filing UUID
- d394f722-cb74-45e0-bcf3-5ad3f8107fae
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Issues related to intellectual property including S. 1553, the PREVAIL Act, S.1546, the Patent Eligibility Restoration Act of 2025, and S.708, the RESTORE Patent Rights Act of 2025
Monitoring Environmental, Social and Governance (ESG) issues Issues related to the sterilization of medical devices Issues related to the use of polyfluoroalkyl substances
Issues related to Medicare coverage and payment for breakthrough medical devices, including Ensuring Patient Access to Critical Breakthrough Products Act (S. 1717; HR 5343) Issues related to Medicare coverage and payment of AI and digital health technologies, including Health Tech Investment Act (S. 1399) Issues related to Medicare Physician Fee Schedule Issues related to H.R. 1, the One Big Beautiful Bill Act Issues related to prior authorization, including CMMI WISeR Model Issues related to DME competitive bidding
Literal federal measure citations: S. 1717, HR 5343, S. 1399, H.R. 1
Issues related to the taxation of multinational corporations corporations, including provisions of H.R. 1, the One Big Beautiful Bill Act
Literal federal measure citations: H.R. 1
Issues related to global supply chains including rare earth and critical minerals Issues related to tariffs Issues related to Japan reimbursement
Issues related to medical device electronic labeling, including H.R. 1539 - Medical Device Electronic Labeling Act Issues related to hypertension Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices, including S.2296 - National Defense Authorization Act for Fiscal Year 2026 and H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 Issues related to artificial intelligence and other advanced software in health care, including provisions of the One Big Beautiful Bill Act Issues related to FDA workforce and product review processes Issues related to H.R. 1, the One Big Beautiful Bill Act Issues related to Parkinsons disease Issues related to diabetes Issues related to epilepsy Issues related to overactive bladder and urinary incontinence
Literal federal measure citations: H.R. 1539, S.2296, H.R. 3838, H.R. 1
Issues related to cybersecurity, including reauthorization of the Cybersecurity Information Sharing Act of 2015
Issues related to data privacy and data security Issues related to artificial intelligence enabled medical devices and emerging technologies Issues related to right to repair
Issues related to hypertension Issues related to procurement of healthcare technologies
Issues related to S.2296 - National Defense Authorization Act for Fiscal Year 2026 and H.R. 3838, the Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 2026 including servicing and repair of medical devices, outbound investment and BIOSECURE
Issues related to hypertension, including FY26 MilCon/Veterans Appropriations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.